引言:子宫腺肌症,我们这个时代的另一种神秘疾病
本文为关于子宫腺肌症的引言,指出其与子宫内膜异位症一样存在争议,特征为子宫内膜腺体存在于子宫肌层。文中讨论两种发病机制理论、症状(盆腔痛、异常出血、不孕)、高质量影像诊断、系统分类需求以及药物和手术治疗策略,强调治疗应依据患者症状和个体需求设计。
要点
- 子宫腺肌症特征为子宫内膜腺体存在于子宫肌层。
- 发病机制有两种主要理论:肌层基底层内陷或苗勒管残余化生/成体干细胞分化。
- 治疗应依据患者症状和个体需求设计,手术治疗仍有争议。
核心结论
- 子宫腺肌症是另一种神秘疾病,仍存在争议,亟需建立系统分类。
主要发现
- 子宫腺肌症可导致盆腔痛、异常出血和不孕。
- 高质量影像可能改善子宫腺肌症的诊断。
- 子宫腺肌症切除术后妊娠期间子宫破裂的风险是现实存在的。
临床怎么用
- 治疗应依据患者症状和个体需求设计。
- 作者强调继续研究基于发病机制的新分子至关重要。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Like endometriosis, uterine adenomyosis is another enigmatic disease and remains a source of controversy. Uterine adenomyosis is characterized by the presence of endometrial glands in the myometrium. Two main theories may explain its pathogenesis: adenomyosis may arise from invagination of the myometrial basalis into the myometrium; or an alternative theory maintains that it may result from metaplasia of displaced embryonic pluripotent müllerian remants or differentiation of adult stem cells. Uterine adenomyosis is responsible for pelvic pain, abnormal bleeding, and infertility. Its diagnosis may be improved by high quality imaging. This issue's Views and Reviews, authors stress the urgent need to establish some systematic classification. Medical and surgical strategies are discussed. It should be emphasized that treatment should be designed according to a patient's symptoms and an individual's needs. Surgical treatment remains a matter of debate. Indeed, the risk of uterine rupture during pregnancy after adenomyomectomy is a reality. Therefore, continued research into new molecules based on the pathogenic mechanisms is vital.
引用
- Donnez J, Donnez O, Dolmans MM, et al. Introduction: Uterine adenomyosis, another enigmatic disease of our time. Fertil Steril. 2018. PMID: 29526476. doi:10.1016/j.fertnstert.2018.01.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。